Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons
U.S. stocks fell: Dow -1.18%, S&P 500 -0.58%, Nasdaq -0.31%. Intel (INTC) +9.05% on price hike plans. Corning (GLW) +7.56% after Verizon (VZ) fiber deal. Amgen (AMGN) -10.08%, Novartis (NVS) -13.93% on drug trial setback. Qualcomm (QCOM) +3.17% on Amazon (AMZN) AI chip deal.
How this was made
The 30-second read
Why it matters
Individual catalysts generated outsized moves that contrast with the overall market weakness.
Market read
Company news created micro‑driven opportunities despite a bearish macro backdrop.
What to watch
The broader market decline may limit upside for even positive news; investors should watch liquidity and macro risk.
Background
The market fell amid rising oil prices and geopolitical tension, but several stocks moved sharply on company‑specific news.
Ticker impact
Intel announced a price hike of up to 10% for its processors, driving a 9% share jump.
Further upside if price hike is implemented across product lines.
Large-cap with immediate 9% move on clear pricing news.
Corning secured an 80‑million‑mile optical‑fiber supply contract with Verizon, lifting the stock 7%.
Potential incremental upside as contract ramps.
Deal size not disclosed but market reacted strongly.
Amgen shares fell 10% after a Phase 3 setback for Novartis’ pelacarsen raised concerns for its own olpasiran program.
Further downside if trial data confirms concerns.
Biotech risk perception drives move; no new data from Amgen itself.
Novartis stock dropped 13.9% after reporting a Phase 3 trial setback for its pelacarsen injectable.
Continued pressure pending further trial updates.
Direct trial result disclosed for the first time.
Qualcomm signed a major AI‑chip deal with Amazon, boosting its stock 3.2%.
Supportive for medium‑term growth.
New partnership with a large cloud customer.
Amazon stock slipped 0.6% after announcing the option to buy up to $60 billion of Qualcomm AI data‑center chips.
Limited short‑term effect; focus on execution.
Price move modest; news is a procurement announcement.
Market effects
Tech hardware and biotech sectors face heightened volatility from pricing moves and trial outcomes.
U.S. equities broadly pressured by oil and geopolitical concerns, but individual tech stocks show divergent reactions.
Oil price surge and trade tensions influence global risk sentiment, while company‑specific news drives isolated stock moves.
Counterpoint
Despite Intel's price hike, higher costs could suppress demand and hurt margins if customers delay purchases.
Key entities
- CompanyIntel
Large‑cap semiconductor maker.
- CompanyCorning
Optical fiber supplier.
- CompanyNovartis
Pharmaceutical giant.
